Rigel Pharmaceuticals, Inc. Financial Ratios — RIGL Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-42.74	-37.64	-35.8	-54.03	-46.86	-94.55	-100.2	-66.96	-81.73	-67.72	-55.63	- -	- -	- -	185.94
Return on Assets (%)	-38.74	-34.86	-33.21	-47.82	-36	-65.96	-79.08	-54.59	-46.67	-23.06	-12.9	-38.84	-19.95	12.44	108.34
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	52.58	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.61	- -
Gross Margin (%)	100	100	100	100	100	100	100	99.36	98.47	99.18	99.27	98.55	93.92	89.6	93.33
EBITDA Margin (%)	-1,777.12	-4,308.62	-1,191.58	-1,077.45	-174.09	-309.23	-1,765.19	-161.96	-115.38	-26.02	-5.24	-44.27	-16.47	14.74	43.46
Operating Margin (%)	-1,818.27	-4,416.76	-1,227.83	-1,106.05	-179.07	-313.84	-1,775.56	-163.3	-116.53	-26.67	-6.01	-45.1	-17.53	13.49	42.63
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	71.61	88.06
Pretax Margin (%)	-1,809.96	-4,392.89	-1,245.13	-1,101.92	-178.11	-339.58	-1,739.34	-158.35	-112.83	-27.38	-11.6	-48.71	-21.47	10.24	41.4
Profit Margin (%)	-1,809.96	-4,392.89	-1,245.13	-1,101.92	-178.11	-339.58	-1,739.34	-158.35	-112.83	-27.38	-12	-48.71	-21.47	9.75	124.72
Net Income to Common Margin (%)	-1,809.96	-4,392.89	-1,245.13	-1,101.92	-178.11	-339.58	-1,739.34	-158.35	-112.83	-27.38	-12	-48.71	-21.47	9.75	124.72
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.8	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-42.74	-37.64	-35.8	-54.03	-46.86	-94.55	-100.2	-66.96	-81.73	-67.72	-55.63	- -	- -	- -	185.94

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	36	39	31	42	61	60	53
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	7	9	10	1	8	8	30
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	29	30	21	40	53	52	23
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.53	-1.38	-3.91	-0.78	-3.15	2.27	0.42
Net Debt/EBITDA	0.22	0.35	0.24	0.17	0.86	0.28	0.48	1.06	0.19	0.37	-0.13	-0.28	-1.39	0.11	0.09
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.53	-1.35	-3.41	-0.77	-2.96	2.48	0.42
Net Debt/EBIT	0.22	0.34	0.24	0.17	0.84	0.28	0.48	1.05	0.18	0.36	-0.11	-0.28	-1.31	0.12	0.09
EBITDA to Interest Expense	-3,376.52	- -	- -	- -	- -	- -	- -	- -	-204.2	-20.89	-1.61	-14.36	-2.8	3.34	17.47
EBITDA-CapEx/Interest Expense	-3,376.52	- -	- -	- -	- -	- -	- -	- -	-204.2	-21.82	-1.74	-14.48	-4.98	3.29	17.47
EBIT to Interest Expense	-3,454.72	- -	- -	- -	- -	- -	- -	- -	-206.24	-21.41	-1.85	-14.63	-2.98	3.06	17.14
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	5	4	7	8	7
Common Equity/Total Assets	91.85	93.24	92.12	83.2	69.36	70.43	84.5	78.99	36.47	30.83	18.15	-10.14	-24.44	2.01	76.22
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	53.96	89.54	68.06	- -	- -	1,593.92	5.84
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	32.22	41.67	33.92	144.68	164.89	82.85	5.14
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	19.68	27.6	12.35	30.1	44.92	31.96	4.45
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.48	114.87	100.63	-305.18	-211.49	1,823.75	13.62
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	40.29	53.46	50.16	148.74	189.69	94.8	11.98
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	24.61	35.41	18.27	30.95	51.68	36.57	10.38
Net Debt to Equity	-7.89	-11.58	-10.01	-11.85	-47.55	-32.04	-38.04	-69.46	-23.62	-31.03	3.37	-110.08	-93.62	89.23	2.99
Net Debt/Capital (%)	-8.57	-13.1	-11.13	-13.45	-90.68	-47.15	-61.41	-227.45	-18.8	-24.7	2.44	430.97	-3,151.12	45.09	2.9
EBITDA	-84	-97	-85	-89	-50	-63	-79	-72	-68	-28	-8	-53	-19	26	128
EBITDA-CapEx	-84	-97	-85	-89	-50	-63	-79	-72	-68	-30	-8	-54	-34	26	128
Operating Income (Loss)	-86	-99	-88	-91	-52	-64	-80	-73	-69	-29	-9	-54	-20	24	125

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	21.48	24.44	20.59	10.21	3.74	3.31	6.31	4.63	1.68	1.4	1.97	0.89	1.07	1.22	1.56
Current Ratio	21.71	24.78	21.38	10.73	3.82	3.37	6.4	4.94	2.04	2.18	2.43	1.78	1.86	2.13	2.42
Quick Ratio	21.48	24.44	21.15	10.62	3.74	3.31	6.31	4.78	1.86	1.79	2.21	1.51	1.64	1.88	2.08
CFO/Avg Current Liab	-6.07	-7.18	-7.65	-5.74	-0.98	-2.69	-3.79	-2.55	-0.97	-1.05	0.11	-1.15	-0.1	0.54	0.93
Common Equity/Total Assets	91.85	93.24	92.12	83.2	69.36	70.43	84.5	78.99	36.47	30.83	18.15	-10.14	-24.44	2.01	76.22
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	53.96	89.54	68.06	- -	- -	1,593.92	5.84
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	32.22	41.67	33.92	144.68	164.89	82.85	5.14
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	19.68	27.6	12.35	30.1	44.92	31.96	4.45
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.48	114.87	100.63	-305.18	-211.49	1,823.75	13.62
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	40.29	53.46	50.16	148.74	189.69	94.8	11.98
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	24.61	35.41	18.27	30.95	51.68	36.57	10.38
CFO/Total Liabilities	-331.03	-406.78	-483.39	-269.43	-58	-328.42	-420.02	-201.24	-44.28	-68.35	4.29	-49.87	-3.94	19.59	61.95
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	-41.35	9.37	-163.91	-0.38	87.42	- -
Altman's Z-Score	12.55	12.86	3.01	-4.75	-6.67	-14.49	3.95	-4.74	-10.46	-11.27	-7.72	-15.15	-17.01	-10.58	2.72

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	2.49	1.43	9.71	200.82	- -	21.83	8.36	8.33	9.49	4.31	3.3	4.97	6.3
Days Sales Outstanding	- -	- -	146.77	254.39	37.6	1.82	- -	16.72	43.67	43.83	38.45	84.68	110.66	73.46	57.91
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.64	0.81	0.6	0.26	0.22	0.97	3.24	2.24
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	568.48	452.83	610.1	1,390.91	1,641.77	375.78	112.79	162.85
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.26	0.26	0.3	1.62	0.32	0.24	3.65	4.77
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	1,394.94	1,408.56	1,216.51	225.89	1,129.22	1,539.88	100	76.49
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-809.74	-912.06	-562.59	1,203.47	597.23	-1,053.44	86.24	144.27
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-551.77	-409.15	-566.28	-1,352.46	-1,557.09	-265.12	-39.32	-104.94
Inventories	- -	- -	- -	- -	- -	- -	- -	1	1	2	7	9	6	6	12
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	5	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	1	1	- -	3	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	2	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	6	12

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	563	566	249	200	274	236	570	384	359	593	455	260	253	298	784
- Cash & Cash Equivalents	19	33	21	15	43	18	38	76	23	30	19	24	33	57	41
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	36	39	31	42	61	60	53
Enterprise Value	316	268	37	57	148	161	454	256	298	574	360	243	257	281	683
Total Capital	236	289	208	128	91	55	101	110	90	73	61	28	32	63	445
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	40.29	53.46	50.16	148.74	189.69	94.8	11.98
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.12	0.07	0.08	0.17	0.24	0.21	0.08
EV/Sales	66.43	119.19	5.24	6.87	5.13	7.92	101.22	5.75	5.02	5.29	2.41	2.02	2.2	1.56	2.32
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.62	5.34
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.6	5.44
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.04	- -	227.76	7.19	6.99
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.24	- -	15.94	7.13	6.99
Diluted Market Cap	500	487	249	199	268	225	490	369	358	591	452	259	252	297	807
Diluted Enterprise Value	481	454	228	184	224	207	452	293	372	599	463	276	280	301	820
EV per Share	44.21	30.77	4.28	6.44	16.36	16.27	30.92	15.31	17.72	33.92	21	14.04	14.71	15.84	37.28
TTM Sales	5	2	7	8	29	20	4	45	59	109	149	120	117	179	294
TTM EBITDA	-84	-97	-85	-89	-50	-63	-79	-72	-68	-28	-8	-53	-19	26	128
TTM Operating Income	-86	-99	-88	-91	-52	-64	-80	-73	-69	-29	-9	-54	-20	24	125
TTM Cash Flow to Firm	-69	-85	-86	-70	-23	-76	-78	-59	-41	-51	11	-70	1	39	98
TTM Free Cash Flow to Firm	-69	-85	-86	-70	-23	-76	-78	-59	-41	-50	12	-70	16	39	98

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-7.2	-5.72	-2.89	-2.85	-11.44	-2.96	-6.32	-6.28	-8.63	-11.6	69.45	-3.53	27.26	9.35	10.67
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.6	5.44
Enterprise Value	316	268	37	57	148	161	454	256	298	574	360	243	257	281	683
Low Price	64.2	53.7	23.1	15.6	20.2	18.82	19.4	19.6	15.6	12.3	23	6.4	7.12	7.48	15.5
EV/Sales	66.43	119.19	5.24	6.87	5.13	7.92	101.22	5.75	5.02	5.29	2.41	2.02	2.2	1.56	2.32
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.62	5.34
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.91	2.1
Price/Earnings Average	-5.68	-6.71	-4.36	-2.84	-5.41	-3.64	-4.67	-7.61	-5.42	-13.18	-34.91	-5.12	-8.95	13.81	1.32
Price/Earnings High	-7.52	-8.68	-7.46	-4.82	-8.94	-5.97	-7.25	-10.73	-6.73	-29.73	-52.34	-10.35	-14.15	29.98	2.56
Price/Earnings Low	-4.73	-4.07	-2.26	-1.5	-3.47	-2.57	-3.14	-4.46	-3.9	-6.98	-21.89	-1.88	-4.94	7.52	0.76
Price/Book Value	2.38	1.96	1.2	1.56	3	4.29	5.66	3.5	6.68	17.42	14.97	-19.1	-8.85	90.6	2
Price/Book Value Average	2.33	2.67	1.87	2.02	3.12	4.82	4.2	5.08	6.76	11.56	20.72	-22.16	-7.87	73.98	1.26
Price/Book Value High	3.09	3.45	3.2	3.43	5.15	7.9	6.53	7.17	8.4	26.07	31.07	-44.76	-12.45	160.62	2.44
Price/Book Value Low	1.94	1.62	0.97	1.07	2	3.4	2.83	2.98	4.87	6.12	12.99	-8.15	-4.35	40.29	0.72
Price/Tangible Book Value	2.38	1.96	1.2	1.56	3	4.29	5.66	3.5	6.68	17.42	14.97	-9.11	-5.96	-12.51	2.14
Price/Tangible Book Value Average	2.33	2.67	1.87	2.02	3.12	4.82	4.2	5.08	6.76	11.56	20.72	-10.56	-5.3	-10.22	1.34
Price/Tangible Book Value High	3.09	3.45	3.2	3.43	5.15	7.9	6.53	7.17	8.4	26.07	31.07	-21.34	-8.39	-22.18	2.61
Price/Tangible Book Value Low	1.94	1.62	0.97	1.07	2	3.4	2.83	2.98	4.87	6.12	12.99	-3.89	-2.93	-5.56	0.77
Price/Sales	105.19	216.57	34.79	24.12	9.27	11.02	109.31	8.3	6.04	5.44	3.03	2.15	2.16	1.65	2.62
Price/Sales Average	102.8	294.75	54.28	31.28	9.63	12.38	81.2	12.05	6.11	3.61	4.19	2.49	1.92	1.35	1.64
Price/Sales High	136.12	381.17	92.9	53.13	15.91	20.28	126.07	16.99	7.6	8.14	6.28	5.04	3.04	2.92	3.19
Price/Sales Low	85.59	178.92	28.2	16.58	6.18	8.71	54.65	7.07	4.4	1.91	2.63	0.92	1.06	0.73	0.95
Price/Cash Flow	-7.2	-5.72	-2.89	-2.85	-11.44	-2.96	-6.32	-6.28	-8.63	-11.32	76.86	-3.51	-43.93	9.4	10.18
Price/Cash Flow Average	-7.04	-7.78	-4.51	-3.7	-11.89	-3.32	-4.69	-9.12	-8.73	-7.51	106.4	-4.07	-39.09	7.67	6.39
Price/Cash Flow High	-9.32	-10.06	-7.72	-6.28	-19.64	-5.45	-7.29	-12.85	-10.85	-16.94	159.53	-8.22	-61.81	16.66	12.42
Price/Cash Flow Low	-5.86	-4.72	-2.34	-1.96	-7.63	-2.34	-3.16	-5.35	-6.29	-3.98	66.71	-1.5	-21.57	4.18	3.69
Price/Free Cash Flow Average	-7.04	-7.78	-4.51	-3.7	-11.89	-3.32	-4.69	-9.12	-8.73	-7.7	96.14	-4.09	24.25	7.63	6.69
Price/Free Cash Flow High	-9.32	-10.06	-7.72	-6.28	-19.64	-5.45	-7.29	-12.85	-10.85	-17.36	144.15	-8.27	38.35	16.57	13.01
Price/Free Cash Flow Low	-5.86	-4.72	-2.34	-1.96	-7.63	-2.34	-3.16	-5.35	-6.29	-4.08	60.28	-1.51	13.38	4.16	3.86
EV/Sales Average	111.94	327.73	51.51	29.57	8.36	12.15	85.83	10.84	6.37	3.7	4.3	2.65	2.17	1.37	1.72
EV/Sales High	149.5	428.18	90.24	51.52	14.79	20.47	137.98	15.98	7.85	8.25	6.4	5.21	3.29	2.96	3.29
EV/Sales Low	92.55	193.09	25.36	14.81	4.83	8.3	54.98	5.65	4.65	2	2.72	1.07	1.3	0.76	1.01
EV/EBITDA Average	-6.3	-7.61	-4.32	-2.74	-4.8	-3.93	-4.86	-6.69	-5.52	-14.22	-82.06	-5.99	-13.16	9.33	3.95
EV/EBITDA High	-8.41	-9.94	-7.57	-4.78	-8.5	-6.62	-7.82	-9.86	-6.81	-31.7	-122.29	-11.77	-19.97	20.11	7.58
EV/EBITDA Low	-5.21	-4.48	-2.13	-1.37	-2.77	-2.68	-3.11	-3.49	-4.03	-7.68	-52.01	-2.41	-7.91	5.14	2.32
EV/EBIT Average	-6.16	-7.42	-4.2	-2.67	-4.67	-3.87	-4.83	-6.64	-5.46	-13.88	-71.44	-5.88	-12.36	10.19	4.02
EV/EBIT High	-8.22	-9.69	-7.35	-4.66	-8.26	-6.52	-7.77	-9.78	-6.74	-30.92	-106.46	-11.55	-18.76	21.96	7.73
EV/EBIT Low	-5.09	-4.37	-2.07	-1.34	-2.7	-2.64	-3.1	-3.46	-3.99	-7.49	-45.28	-2.36	-7.43	5.61	2.36
Last Price	78.9	65	28.5	22.7	30.3	23.8	38.8	23	21.4	35	26.5	15	14.5	16.82	42.83
High Price	102.1	114.4	76.1	50	52	43.8	44.75	47.1	26.9	52.4	55	35.15	20.4	29.82	52.24
Enterprise Value Average	532	737	368	244	241	248	385	482	378	402	641	319	253	246	505
Enterprise Value High	710	963	645	425	427	417	619	711	466	896	955	627	384	531	969
Enterprise Value Low	440	434	181	122	139	169	247	251	276	217	406	128	152	136	297

Shares Outstanding	7	9	9	9	9	10	15	17	17	17	17	17	17	18	18
Diluted Weighted Avg Shares	6	7	9	9	9	9	13	16	17	17	17	17	17	18	19
Basic Weighted Avg Shares	6	7	9	9	9	9	13	16	17	17	17	17	17	18	18
Revenue per Share	0.75	0.3	0.82	0.94	3.27	2.16	0.35	2.77	3.54	6.44	8.75	6.97	6.72	10.2	16.36
EBITDA per Share	-13.33	-12.93	-9.76	-10.14	-5.69	-6.68	-6.27	-4.49	-4.09	-1.68	-0.46	-3.09	-1.11	1.5	7.11
Operating Income per Share	-13.64	-13.26	-10.06	-10.41	-5.85	-6.78	-6.3	-4.53	-4.13	-1.72	-0.53	-3.15	-1.18	1.38	6.98
Basic EPS, GAAP	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	20.4
Basic EPS from Cont Ops	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	20.4
Diluted EPS, GAAP	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	19.48
Diluted EPS from Cont Ops	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	19.48
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-10.95	-11.37	-9.86	-7.96	-2.65	-8.04	-6.14	-3.66	-2.48	-3.09	0.34	-4.28	-0.33	1.79	4.21
Free Cash Flow per Basic Share	-10.95	-11.37	-9.86	-7.96	-2.65	-8.04	-6.14	-3.66	-2.48	-3.17	0.31	-4.3	-1.19	1.77	4.21
Cash & Equivalents per Share	34.69	34.23	24.22	16.26	13.94	7.53	7.88	7.69	5.84	3.39	7.28	3.36	3.26	4.37	8.46
Book Value per Share	33.08	33.18	23.79	14.57	10.09	5.54	6.86	6.57	3.2	2.01	1.77	-0.79	-1.64	0.19	21.38
Tangible Book Value per Share	33.08	33.18	23.79	14.57	10.09	5.54	6.86	6.57	3.2	2.01	1.77	-1.65	-2.43	-1.34	20.03

Rigel Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)